Axq Capital »

C4 Therapeutics shares owned by Axq Capital

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Axq Capital from 13F filings

Historical chart of Axq Capital investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Axq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Axq Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $227k 86k 2.63

More positions owned by Axq Capital

Boston Scientific Corporation (BSX)
Cleveland-cliffs (CLF)
Otis Worldwide Corp (OTIS)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Blackrock (BLK)
Ford Motor Company (F)
TPG Com Cl A (TPG)
Dollar Tree (DLTR)
3M Company (MMM)
Antero Midstream Corp antero midstream (AM)
Rocket Cos Com Cl A (RKT)
TransDigm Group Incorporated (TDG)
Insulet Corporation (PODD)
Wec Energy Group (WEC)
Colgate-Palmolive Company (CL)

View all positions for Axq Capital

Top funds holding C4 Therapeutics

Morgan Stanley
RA Capital Management
Bain Capital Life Sciences Investors
Lynx1 Capital Management
Vanguard Group
Vanguard Capital Management
Soleus Capital Management
Two Sigma Investments
Daniel D. Thurber
Citadel Advisors
Goldman Sachs Group
Bank of America Corporation
Squadron Capital Management
BlackRock
Silverarc Capital Management

View all funds holding C4 Therapeutics